# To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

> **NCT02015273** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 82 (actual)

## Conditions studied

- Growth Disorders

## Interventions

- **DEVICE:** easypod™

## Key facts

- **NCT ID:** NCT02015273
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-28
- **Primary completion:** 2015-12-31
- **Final completion:** 2015-12-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015273, "To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02015273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*